Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure

Coronary vein graft disease: Pathogenesis and prevention

(2011) Pirouz Parang et al.   CANADIAN JOURNAL OF CARDIOLOGY

Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial

(2011) Emmanouil S. Brilakis et al.   JACC-Cardiovascular Interventions

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial

(2011) Julinda Mehilli et al.   LANCET

Coronary artery disease progression in patients who need repeat surgical revascularisation: the surgeonʼs point of view

(2010) Andreas Borowski et al.   Journal of Cardiovascular Medicine

Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis

(2010) Pascal Meier et al.   PLoS One

Safety and Efficacy of Drug-Eluting and Bare Metal Stents

(2009) Ajay J. Kirtane et al.   CIRCULATION

A Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions

(2009) Emmanouil S. Brilakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions

(2008) Raban V. Jeger et al.   CARDIOLOGY

EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention

(2008) E Romagnoli et al.   HEART